January 07, 2026

AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings

Researchers explored whether artificial intelligence (AI) models pretrained on vast data sets may outperform standard baseline models in identifying nonmelanoma skin cancers, according to findings pre...

The ASCO Post

January 02, 2026

Miami Cancer Institute Precision Oncology Symposium, Fourth Annual

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors, including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors by novel targeted agents and treatment combinations.

Baptist Health South Florida

December 17, 2025

Building the Cancer Care Africa Deserves

There is something deeply moving about watching hope take shape, not as a slogan or a speech, but as people coming together to build the cancer care Africa deserves. The African Organization for Resea...

The ASCO Post

December 09, 2025

How AI Is Ushering in a New Era in Cancer Care

On October 30, 2025, Google Cloud held its second annual Cancer AI Symposium to explore how artificial intelligence (AI) is advancing cancer research, diagnosis, and treatment, in unparalleled ways. H...

The ASCO Post

December 09, 2025

SOHO 2025 Keynote Speakers Highlight Progress in Hematologic Oncology

Three Plenary Sessions were presented recently at the 2025 Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), which focused specifically on new advances and practical clinical applicat...

The ASCO Post

November 18, 2025

Roswell Park at ASH 2025

Roswell Park invites you to come meet some of our nationally recognized experts in transplant and cellular therapy and hematologic malignancies at this year’s ASH conference in Orlando, taking place December 6-9, 2025. 

Roswell Park Comprehensive Cancer Center

November 05, 2025

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will discuss their latest discoveries at the 67th annual meeting of the American Society of Hematology (ASH) December 6-9 in Orlando, Florida.

Roswell Park Comprehensive Cancer Center

October 31, 2025

A Young Hematologist’s Take on ICML 2025

From Dr. Bruce Cheson’s electric speech on how it all started with pentostatin in hairy cell leukemia, to the introduction of bendamustine in indolent lymphoma, to the development of R-squared (an inn...

The ASCO Post

October 19, 2025

ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared to standard chemotherapy.

Dana-Farber